Home > Income Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Expenditure

    Back to Income Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Expenditure History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Total Expenditure ₹234 Cr₹204 Cr₹200 Cr₹16,826,961 Cr₹167 Cr

What is the latest Total Expenditure of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Expenditure ratio of SYNCOM FORMULATIONS (INDIA) is ₹234 Cr based on Mar2025 Consolidated results.
Year Total Expenditure
Mar2025₹234 Cr
Mar2024₹204 Cr
Mar2023₹200 Cr
Mar2022₹16,826,961 Cr
Mar2017₹167 Cr

How is Total Expenditure of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Expenditure % Change
Mar2025 ₹234 Cr
14.38
Mar2024 ₹204 Cr
2.37
Mar2023 ₹200 Cr
-100.00
Mar2022 ₹16,826,961 Cr
10,062,186.55
Mar2017 ₹167 Cr -

Compare Total Expenditure of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,222.0 Cr 15% 8.3% -23.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,050.0 Cr 1.3% -4.5% -0% Stock Analytics
DIVIS LABORATORIES ₹158,157.0 Cr 1.7% -5.9% 3.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,531.0 Cr 2.6% -5% 25.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,190.0 Cr -0.4% -7% 3.6% Stock Analytics
CIPLA ₹98,892.8 Cr 2.6% -7.4% -16.3% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

15%

8.3%

-23.3%

SENSEX

4.8%

-4.2%

0.8%


You may also like the below Video Courses